Grant: Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI - Next-generation prev. technologies
University of Toronto
$200,000.00
Formulating a broadly cross-protective TbpB-based vaccine to combat Neisseria gonorrhoeae.
FY 2024-25
Summary
Neisseria gonorrhoeae causes the sexually-transmitted disease, gonorrhea. This bacteria is considered an urgent threat to global health due to recent dramatic increases in the number of infections, both within Canada and globally, and due to the emergence of multi-drug resistant 'superbug' strains that are resistant to treatment. This research proposal describes a focused attempt to extend the coverage of a vaccine that we have recently shown can protect female mice from becoming infected by N. gonorrhoeae. This vaccine targets the bacteria's transferrin receptor, which allows the gonococci to acquire iron while infecting human tissues. This capacity is critical because iron is required for growth and cell division, so is essential to support life. While our transferrin receptor-based vaccine is effective, some strains express a variant receptor that is distinct and so these strains avoid the protective effect of the vaccine. We will, therefore, extend the coverage of the vaccine to target both receptor variants, allowing it to protect against all known strains of N. gonorrhoeae.
Department
Program
Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI - Next-generation prev. technologies
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
521664
Name
Gray-Owen Scott D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant : Biomedical Research for HIV/AIDS and STBBI
Projecttitle
Formulating a broadly cross-protective TbpB-based vaccine to combat Neisseria gonorrhoeae.
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$200,000
Cihrequipment2
$0
Programname2
Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI - Next-generation prev. technologies
Keyworddelim
Bacterial Infection; Gonorrhea; Neisseria Gonorrhoeae; Sexually Transmitted Infection; Vaccine
Abstract
Neisseria gonorrhoeae causes the sexually-transmitted disease, gonorrhea. This bacteria is considered an urgent threat to global health due to recent dramatic increases in the number of infections, both within Canada and globally, and due to the emergence of multi-drug resistant 'superbug' strains that are resistant to treatment. This research proposal describes a focused attempt to extend the coverage of a vaccine that we have recently shown can protect female mice from becoming infected by N. gonorrhoeae. This vaccine targets the bacteria's transferrin receptor, which allows the gonococci to acquire iron while infecting human tissues. This capacity is critical because iron is required for growth and cell division, so is essential to support life. While our transferrin receptor-based vaccine is effective, some strains express a variant receptor that is distinct and so these strains avoid the protective effect of the vaccine. We will, therefore, extend the coverage of the vaccine to target both receptor variants, allowing it to protect against all known strains of N. gonorrhoeae.
Competitiondate
202410
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gray-Owen, Scott D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $200,000~ $0~